Physician profile
Gina Stephen
NPI 1730485418
$1,725.47
in general payments reported to CMS, 2019-2025
23 companies · $513 in 2025
The $513 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $71.47 · 2021: $121 · 2022: $125 · 2023: $297 · 2024: $354 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $287.49 | 2022-2025 | Azstarys |
| Cranial Technologies, INC | $233.02 | 2019-2025 | Doc Band |
| Supernus Pharmaceuticals, INC. | $209.30 | 2024-2025 | Qelbree |
| Sanofi Pasteur INC. | $129.67 | 2019-2023 | |
| Tris Pharma INC | $105.86 | 2023-2025 | Onyda Xr, Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $96.18 | 2020-2025 | Vpriv, Elaprase |
| Merck Sharp & Dohme LLC | $87.09 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Pfizer INC. | $86.77 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $70.97 | 2019-2024 | |
| Ars Pharmaceuticals Operations, INC. | $66.56 | 2025 | Neffy |
| Collegium Pharmaceutical, INC. | $58.55 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $44.12 | 2025 | |
| Shire North American Group INC | $41.63 | 2019 | |
| Seqirus USA INC | $32.18 | 2023 | Flucelvax Quadrivalent |
| Sobi, INC | $30.82 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $28.39 | 2024 | Crysvita |
| Biogen, INC. | $22.08 | 2023 | Spinraza |
| Kaleo, INC. | $19.53 | 2024 | Auvi-Q |
| Noven Therapeutics, LLC | $17.00 | 2025 | Xelstrym |
| Nestle Healthcare Nutrition INC. | $15.40 | 2022 | |
| Aytu Biopharma, INC. | $14.95 | 2025 | |
| Neos Therapeutics, LP | $14.48 | 2025 | Cotempla Xr-Odt |
| Novartis Pharmaceuticals Corporation | $13.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gina Stephen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.